Download Files:
Inavolisib
Price range: 128 CAD through 3,808 CAD
Products Details
Product Description
– Inavolisib (GDC-0077) is an orally available selective PI3Kα inhibitor with an IC50 value of 0.038 nM.It exerts its activity by binding to the ATP-binding site of PI3K, thereby inhibiting the phosphorylation of PIP2 to PIP3.
Web ID
– T15375
Storage Temperature
– -20℃
Shipping
– Blue Ice
Molecular Formula
– C18H19F2N5O4
References
– R Hong, Abstract PD4-14: GDC-0077 is a selective PI3Kalpha inhibitor that demonstrates robust efficacy in PIK3CA mutant breast cancer models as a single agent and in combination with standard of care therapies. 2017 San Antonio Breast Cancer Symposium.
CAS Number
– 2060571-02-8
Molecular Weight
– C18H19F2N5O4
Compound Purity
– 0.9987
SMILES
– C[C@H](Nc1ccc2-c3nc(cn3CCOc2c1)N1[C@@H](COC1=O)C(F)F)C(N)=O
Target
– Others
Pathway
– PI3K/Akt/mTOR signaling|||Apoptosis
Product type
– Small Compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
Related Products
1000 in stock
